Page 1 - PHESGO (PERTUZUMAB-TRASTUZUMAB) - Product Monograph
P. 1

PERTUZUMAB-TRASTUZUMAB


                                                        PHESGO   ®
                             (pertuzumab-trastuzumab fixed-dose combination for subcutaneous injection)


                           PLUS CHEMOTHERAPY FOR THE NEOADJUVANT AND ADJUVANT TREATMENT OF
                        HER2-POSITIVE EARLY BREAST CANCER (eBC) AND FOR THE FIRST-LINE TREATMENT OF
                                      HER2-POSITIVE METASTATIC BREAST CANCER (mBC)

                                   PRODUCT MONOGRAPH










           M-AE-00000086
   1   2   3   4   5   6